Trial Information

Summary: Parkinson's Disease - Deep Brain Stimulation

A clinical evaluation of bilateral stimulation of the Subthalamic Nucleus (STN) using a Brain Stimulation System as an adjunctive treatment for reducing some of the symptoms of advanced levodopa-responsive Parkinson’s disease that are not adequately controlled with medication.

You may qualify for this study if you:

  • Are between 18 and 80 years old
  • Have been diagnosed with Parkinson’s disease for a least five years
You will not qualify for this study if you:
  • Have other medically significant disease
  • Require frequent repeated MRI scans
  • Have a pacemaker or prosthesis
  • Currently abuse drugs or alcohol
  • Have a history of cranial surgery
  • Have a history of seizures
  • Have any metallic implants
  • Are pregnant

Contact:

Ricardo Renvill, Study Coordinator
Biomedical Research Alliance of New York
Mount Sinai School of Medicine
1468 Madison Avenue
Rm 2-40, 2nd Floor
New York, NY 10026
Telephone: 212-241-4633
Email:

Profile Page: Biomedical Research Alliance of New York, New York, NY

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:45:27 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA